Page last updated: 2024-10-21

5-methoxytryptamine and Autosomal Dominant Juvenile Parkinson Disease

5-methoxytryptamine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 3 studies

5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Willis, GL3
Robertson, AD2

Trials

1 trial available for 5-methoxytryptamine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 80, Issue:1

    Topics: 5-Methoxytryptamine; Animals; Behavior, Animal; Callithrix; Cross-Over Studies; Eating; Male; Melato

2005

Other Studies

2 other studies available for 5-methoxytryptamine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 79, Issue:3

    Topics: 5-Methoxytryptamine; Animals; Male; Melatonin; Naphthalenes; Oxidopamine; Parkinsonian Disorders; Ra

2004
Intraocular microinjections repair experimental Parkinson's disease.
    Brain research, 2008, Jun-27, Volume: 1217

    Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Circadian Rhythm; Levodopa; Male; Microinjection

2008